Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Shingles; Sickness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received first dose of Shingles vaccine on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sickness) and shingles (Verbatim: Shingles). The outcome of the sickness was not reported (duration 8 weeks) and the outcome of the shingles was not reported. It was unknown if the reporter considered the sickness and shingles to be related to Shingles vaccine. It was unknown if the company considered the sickness and shingles to be related to Shingles vaccine. Additional Information: GSK receipt date: 25-JAN-2026 This case was reported by a consumer via interactive digital media. The patient reported that they had been fine after the first shot but had experienced all the listed symptoms and more after the second shot. They stated that they had been very sick. The patient mentioned that they had usually been okay with vaccines (except the Covid vaccine), but this reaction had been even worse than that. They added that they never wanted to receive it again. The batch number was not provided, and we are unable to contact the reporter.